About-cancer/screening/research/zh

筛选研究

肺癌筛查后，后续程序可能比想像中要冒险

发表于：二月8，2019

在日常医疗保健中，肺癌筛查后进行的侵入性诊断程序可能比大型研究报告的并发症更多。

关键数字：癌症筛查统计真正告诉我们的是什么

更新时间：2018年7月16日

癌症筛查研究表明，更多的筛查不一定意味着更少的癌症死亡。 本文介绍了如何解释用于描述筛选研究结果的统计数据。

互动应用程序可提高大肠癌筛查率

发表于：四月9，2018

结肠直肠癌筛查可减少因疾病而导致的死亡，但约有三分之一的美国人尚未进行筛查。 了解当等待例行检查的人们使用允许他们订购自己的筛查测试的应用时发生了什么。

为了预防遗传性癌症，研究人员专注于林奇综合症

更新日期：2017年8月8日

在NCI主持的研讨会上，专家们讨论了与使用Lynch综合征作为预防遗传性癌症的模型有关的问题。

NCI研究表明Li-Fraumeni综合征患者进行癌症筛查方案的可行性

发表于：八月3，2017

NCI的一项新研究表明，针对Li-Fraumeni综合征（一种罕见的遗传性疾病，导致罹患某些癌症的风险更高）进行全面筛查的可行性。

在精密医学时代，测试乳腺癌筛查的新方法

发表于：五月9，2017

研究人员正在测试能够识别需要筛查的乳腺癌风险个体化方法，并测试适合每个人风险水平的筛查间隔。

肺癌筛查飞行员揭示了挑战，痛苦越来越大

发表于：二月27，2017

退伍军人健康管理局（Veterans Health Administration）的一个示范项目强调了与美国肺癌筛查扩展有关的一些复杂性和挑战。

Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches

Posted: June 2, 2016

A blog post on a modeling study from NCI researchers suggesting that individualized, risk-based selection of ever-smokers for lung cancer screening may prevent more lung cancer deaths compared with current screening recommendations.

Bringing Precision to Screening for Cancer

Posted: November 17, 2015

A recent NCI-sponsored conference brought together leading screening and cancer control researchers to discuss the state of the science of precision screening for five cancers.

Overdiagnosis of Cancer: Bringing an Important Problem into Focus

Posted: August 28, 2015

Experts are convening for a conference on the dilemmas posed by overdiagnosis in many types of diseases. Overdiagnosis is generally defined as the diagnosis of a disease or condition that is unlikely to ever cause harm.

Screening Rates for Several Cancers Miss Their Targets

Posted: May 26, 2015

Screening rates for breast, colorectal, and cervical cancer are lagging behind target rates set by the Healthy People 2020 program, according to a new study.

NIH study finds negative HPV screening test result is a better predictor of low cervical cancer risk than a negative Pap test

Posted: July 18, 2014

Based on a study that included more than 1 million women, investigators at NCI have determined that a negative test for HPV infection compared to a negative Pap test provides greater safety, or assurance, against future risk of cervical cancer.